Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Autologous Plasma Rich in Platelets and Focal Shock Waves for the Erectile Dysfunction Treatment

NCT06433596 is registered in ClinicalTrials.gov with Elexial Research Limited as lead sponsor.

NCT NCT06433596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06433596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Autologous Plasma Rich in Platelets and Focal Shock Waves for the Erectile Dysfunction Treatment
Lead sponsor
Elexial Research Limited
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 6, 2024
Completion date
February 28, 2027
Enrollment
116 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction